NM_031433.4:c.355A>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_031433.4(MFRP):​c.355A>G​(p.Ile119Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00283 in 1,613,524 control chromosomes in the GnomAD database, including 119 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.015 ( 67 hom., cov: 32)
Exomes 𝑓: 0.0016 ( 52 hom. )

Consequence

MFRP
NM_031433.4 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.0230

Publications

8 publications found
Variant links:
Genes affected
MFRP (HGNC:18121): (membrane frizzled-related protein) This gene encodes a member of the frizzled-related protein family. The encoded protein plays an important role in eye development and mutations in this gene have been associated with nanophthalmos, posterior microphthalmia, retinitis pigmentosa, foveoschisis, and optic disc drusen. The protein is encoded by a bicistronic transcript which also encodes C1q and tumor necrosis factor related protein 5 (C1QTNF5). [provided by RefSeq, Jun 2013]
C1QTNF5 (HGNC:14344): (C1q and TNF related 5) This gene encodes a member of a family of proteins that function as components of basement membranes and may play a role in cell adhesion. Mutations in this gene have been associated with late-onset retinal degeneration. The protein may be encoded by either a bicistronic transcript including sequence from the upstream membrane frizzled-related protein gene (MFRP), or by a monocistronic transcript expressed from an internal promoter. [provided by RefSeq, Jun 2013]
C1QTNF5 Gene-Disease associations (from GenCC):
  • late-onset retinal degeneration
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0026126802).
BP6
Variant 11-119345845-T-C is Benign according to our data. Variant chr11-119345845-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 197357.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0525 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MFRPNM_031433.4 linkc.355A>G p.Ile119Val missense_variant Exon 4 of 15 ENST00000619721.6 NP_113621.1 Q9BY79-1
C1QTNF5NM_015645.5 linkc.-2282A>G 5_prime_UTR_variant Exon 4 of 15 NP_056460.1 Q9BXJ0A0A024R3F8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MFRPENST00000619721.6 linkc.355A>G p.Ile119Val missense_variant Exon 4 of 15 1 NM_031433.4 ENSP00000481824.1 Q9BY79-1

Frequencies

GnomAD3 genomes
AF:
0.0147
AC:
2233
AN:
151730
Hom.:
66
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0512
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00551
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000416
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000132
Gnomad OTH
AF:
0.0120
GnomAD2 exomes
AF:
0.00405
AC:
1003
AN:
247844
AF XY:
0.00284
show subpopulations
Gnomad AFR exome
AF:
0.0548
Gnomad AMR exome
AF:
0.00263
Gnomad ASJ exome
AF:
0.0000998
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000724
Gnomad OTH exome
AF:
0.00214
GnomAD4 exome
AF:
0.00159
AC:
2328
AN:
1461676
Hom.:
52
Cov.:
36
AF XY:
0.00138
AC XY:
1002
AN XY:
727118
show subpopulations
African (AFR)
AF:
0.0546
AC:
1828
AN:
33480
American (AMR)
AF:
0.00306
AC:
137
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26130
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000232
AC:
20
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53266
Middle Eastern (MID)
AF:
0.00295
AC:
17
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000531
AC:
59
AN:
1111966
Other (OTH)
AF:
0.00440
AC:
266
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
159
318
476
635
794
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
64
128
192
256
320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0147
AC:
2238
AN:
151848
Hom.:
67
Cov.:
32
AF XY:
0.0147
AC XY:
1091
AN XY:
74234
show subpopulations
African (AFR)
AF:
0.0512
AC:
2119
AN:
41382
American (AMR)
AF:
0.00550
AC:
84
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3462
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5138
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4802
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10562
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000132
AC:
9
AN:
67928
Other (OTH)
AF:
0.0119
AC:
25
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
102
203
305
406
508
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00549
Hom.:
62
Bravo
AF:
0.0171
ESP6500AA
AF:
0.0480
AC:
211
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.00493
AC:
599
Asia WGS
AF:
0.00491
AC:
18
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.000119

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Isolated microphthalmia 5 Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Feb 23, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nanophthalmos 2;C1970236:Isolated microphthalmia 5 Benign:1
Mar 31, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Retinal degeneration Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Late-onset retinal degeneration Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Benign
-0.59
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
3.6
DANN
Benign
0.78
DEOGEN2
Benign
0.049
T;.
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.076
N
LIST_S2
Benign
0.32
T;T
MetaRNN
Benign
0.0026
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.34
N;N
PhyloP100
-0.023
PrimateAI
Benign
0.26
T
PROVEAN
Benign
-0.19
.;N
REVEL
Benign
0.042
Sift
Benign
0.31
.;T
Sift4G
Benign
0.54
T;T
Polyphen
0.0020
B;.
Vest4
0.11
MVP
0.28
ClinPred
0.0080
T
GERP RS
2.8
Varity_R
0.018
gMVP
0.24
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4639950; hg19: chr11-119216555; COSMIC: COSV64128619; COSMIC: COSV64128619; API